Apollomics, Inc. (APLM) vs biote Corp. (BTMD)
A side-by-side comparison of Apollomics, Inc. and biote Corp. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
APLM
Apollomics, Inc.
$22.59HealthcareDelayed quote: Oct 6, 2026, 1:50 PM EDT
BTMD
biote Corp.
$1.21HealthcareDelayed quote: Oct 6, 2026, 1:47 PM EDT
Total return — APLM vs BTMD
growth of $100 · dividends reinvested · last 5yAPLM -97.6% (-52.8%/yr)BTMD -88.5% (-35.1%/yr)BTMD compounded faster over this window
APLM BTMD
APLM vs BTMD: by the numbers
- •BTMD is the larger company ($53M vs $50M market cap).
- •BTMD is profitable (3.19% net margin) while APLM runs a net loss (-128.69%).
- •APLM grew revenue faster over the past five years (35.84% vs 10.52% CAGR).
Metrics side by side
Valuation
| Metric | APLM | BTMD |
|---|---|---|
| P/E ratio | N/A | 10.37 |
| P/S ratio | N/A | 0.29 |
| EV / EBITDA | N/A | 9.19 |
| FCF yield | N/A | 36.88% |
Profitability
| Metric | APLM | BTMD |
|---|---|---|
| Gross margin | 97.00% | 71.46% |
| Operating margin | -111.45% | 18.50% |
| Net margin | -128.69% | 3.19% |
| ROIC | -2441.49% | 13.63% |
Growth (annualized)
| Metric | APLM | BTMD |
|---|---|---|
| Revenue CAGR (5Y) | 35.84% | 10.52% |
| EPS CAGR (5Y) | N/A | -25.90% |
| FCF CAGR (5Y) | N/A | 3.81% |
| Total return CAGR (5Y) | N/A | -35.12% |
Frequently asked
- Which has grown faster, APLM or BTMD?
- Over the past five years, APLM grew revenue faster — APLM at a 35.84% CAGR versus BTMD at 10.52%.
- Is APLM or BTMD more profitable?
- BTMD runs the higher net margin — APLM at -128.69% versus BTMD at 3.19%.
Go deeper
Dig into the metrics
biote P/E ratioApollomics ROEbiote ROEApollomics operating marginbiote operating marginApollomics revenue growthbiote revenue growthApollomics free cash flowbiote free cash flow
Apollomics & biote appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.